Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study

Aims To evaluate the clinical features and impact of flash glucose monitoring in older adults with type 1 diabetes (T1D) across age groups defined as young‐old, middle‐old, and old‐old. Materials and Methods Clinicians were invited to submit anonymized intermittently scanned continuous glucose monit...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes, obesity & metabolism obesity & metabolism, 2024-04, Vol.26 (4), p.1333-1339
Main Authors: Deshmukh, Harshal, Adeleke, Kazeem, Wilmot, Emma G., Folwell, Anna, Barnes, Dennis, Walker, Neil, Saunders, Simon, Ssemmondo, Emmanuel, Walton, Chris, Patmore, Jane, Ryder, Robert E. J., Sathyapalan, Thozhukat
Format: Article
Language:English
Subjects:
Age groups
continuous glucose monitoring (CGM)
Diabetes
Diabetes mellitus (insulin dependent)
Glucose monitoring
glycaemic control
Hemoglobin
Hypoglycemia
Insulin
Older people
real‐world evidence
Resource utilization
type 1 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims To evaluate the clinical features and impact of flash glucose monitoring in older adults with type 1 diabetes (T1D) across age groups defined as young‐old, middle‐old, and old‐old. Materials and Methods Clinicians were invited to submit anonymized intermittently scanned continuous glucose monitoring (isCGM) user data to a secure web‐based tool within the National Health Service secure network. We collected baseline data before isCGM initiation, such as demographics, glycated haemoglobin (HbA1c) values from the previous 12 months, Gold scores and Diabetes Distress Scale (DDS2) scores. For analysis, people with diabetes were classified as young‐old (65–75 years), middle‐old (>75–85 years) and old‐old (>85 years). We compared baseline clinical characteristics across the age categories using a t test. All the analyses were performed in R 4.1.2. Results The study involved 1171 people with diabetes in the young‐old group, 374 in the middle‐old group, and 47 in the old‐old group. There were no significant differences in baseline HbA1c and DDS2 scores among the young‐old, middle‐old, and old‐old age groups. However, Gold score increased with age (3.20 [±1.91] in the young‐old vs. 3.46 [±1.94] in the middle‐old vs. 4.05 [±2.28] in the old‐old group; p 
ISSN:1462-8902
1463-1326
DOI:10.1111/dom.15434